Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-04
DOI
10.1038/s41467-020-20259-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deubiquitinase USP47-stabilized splicing factor IK regulates the splicing of ATM pre-mRNA
- (2020) Hye In Ka et al. Cell Death Discovery
- Reversible regulation of SATB1 ubiquitination by USP47 and SMURF2 mediates colon cancer cell proliferation and tumor progression
- (2019) Le Yu et al. CANCER LETTERS
- ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP
- (2019) Francesca Bufalieri et al. Nature Communications
- MicroRNA-204-5p Inhibits Ovarian Cancer Cell Proliferation by Down-Regulating USP47
- (2019) Liangliang Hu et al. CELL TRANSPLANTATION
- LINC00668 promotes tumorigenesis and progression through sponging miR-188–5p and regulating USP47 in colorectal cancer
- (2019) Shuai Yan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer
- (2019) Beiqing Pan et al. Protein & Cell
- Ubiquitin-specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance and Inflammation via Sirt6
- (2018) Pengcheng Luo et al. HEPATOLOGY
- LZTR1 is a regulator of RAS ubiquitination and signaling
- (2018) Johannes W. Bigenzahn et al. SCIENCE
- Inhibition of USP10 induces degradation of oncogenic FLT3
- (2017) Ellen L Weisberg et al. Nature Chemical Biology
- Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target
- (2017) Pramod Kumar Maurya et al. Journal of Cancer
- Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
- (2017) Asmus Heumann et al. Scientific Reports
- Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail: A potential role of Sox9
- (2017) Bae-Jung Choi et al. Scientific Reports
- A role for FOXO1 in BCR–ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia
- (2016) M Wagle et al. LEUKEMIA
- HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma
- (2016) Omid Tavana et al. NATURE MEDICINE
- Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
- (2016) Gianantonio Rosti et al. Nature Reviews Clinical Oncology
- The Deubiquitinase USP47 Stabilizes MAPK by Counteracting the Function of the N-end Rule ligase POE/UBR4 in Drosophila
- (2016) Dariel Ashton-Beaucage et al. PLOS BIOLOGY
- Deubiquitinase USP47/UBP64E Regulates β-Catenin Ubiquitination and Degradation and Plays a Positive Role in Wnt Signaling
- (2015) Jiandang Shi et al. MOLECULAR AND CELLULAR BIOLOGY
- MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A
- (2014) Binbin Zhang et al. MEDICAL ONCOLOGY
- Minus end–directed motor KIFC3 suppresses E-cadherin degradation by recruiting USP47 to adherens junctions
- (2014) Kyoko Sako-Kubota et al. MOLECULAR BIOLOGY OF THE CELL
- A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
- (2014) L. Ma et al. Science Translational Medicine
- Ponatinib in the leukemia world: why a reevaluation is necessary for Philadelphia chromosome-positive patients withT315Imutation
- (2014) Angelina Daisy Goodrich Expert Review of Hematology
- Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile
- (2013) K. Cramer-Morales et al. BLOOD
- Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells
- (2013) E. Bolton-Gillespie et al. BLOOD
- Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma
- (2013) Y Fujiwara-Okada et al. BRITISH JOURNAL OF CANCER
- USP47 and C Terminus of Hsp70-Interacting Protein (CHIP) Antagonistically Regulate Katanin-p60-Mediated Axonal Growth
- (2013) S. W. Yang et al. JOURNAL OF NEUROSCIENCE
- BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP
- (2013) A Morotti et al. LEUKEMIA
- A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
- (2013) J.E. Cortes et al. NEW ENGLAND JOURNAL OF MEDICINE
- YB-1 disrupts mismatch repair complex formation, interferes with MutSα recruitment on mismatch and inhibits mismatch repair through interacting with PCNA
- (2013) Y-W Chang et al. ONCOGENE
- Deubiquitylases From Genes to Organism
- (2013) Michael J. Clague et al. PHYSIOLOGICAL REVIEWS
- A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
- (2012) Dharminder Chauhan et al. CANCER CELL
- MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop
- (2012) Tobias Sinnberg et al. EXPERIMENTAL DERMATOLOGY
- Cellular functions of the DUBs
- (2012) M. J. Clague et al. JOURNAL OF CELL SCIENCE
- The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival
- (2012) K S Bommert et al. LEUKEMIA
- The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability
- (2012) W-C Yang et al. ONCOGENE
- Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47
- (2012) Joseph Weinstock et al. ACS Medicinal Chemistry Letters
- Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis
- (2011) H. Sun et al. BLOOD
- Mutant BCR-ABL clones in chronic myeloid leukemia
- (2011) M. S. Mathisen et al. HAEMATOLOGICA
- BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance
- (2011) Hilmar Quentmeier et al. Journal of Hematology & Oncology
- USP47 Is a Deubiquitylating Enzyme that Regulates Base Excision Repair by Controlling Steady-State Levels of DNA Polymerase β
- (2011) Jason L. Parsons et al. MOLECULAR CELL
- BCR-ABL stimulates mutagenic homologous DNA double-strand break repair via the DNA-end-processing factor CtIP
- (2010) Daniela Salles et al. CARCINOGENESIS
- USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
- (2010) Jian Yuan et al. CELL
- BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4
- (2009) Momoko Suzuki et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The ubiquitin-specific protease USP47 is a novel β-TRCP interactor regulating cell survival
- (2009) A Peschiaroli et al. ONCOGENE
- Regulatory Role of Human AP-Endonuclease (APE1/Ref-1) in YB-1-Mediated Activation of the Multidrug Resistance Gene MDR1
- (2008) R. Chattopadhyay et al. MOLECULAR AND CELLULAR BIOLOGY
- The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma
- (2007) M. Chatterjee et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search